Medical

The FDA rules just changed on COVID-10 monoclonal antibody treatments

The FDA rules just changed on COVID-10 monoclonal antibody treatments

The U.S. Food and Drug Administration (FDA) has just released a new update in regards to the treatment options for COVID-19. As a result of the update, the FDA has removed the authorization for two monoclonal antibody treatments. Starting January 24, 2022, these treatments will only be authorized in certain regions.

Continue Reading

FDA wants more info before approving Merck’s chronic cough drug

FDA wants more info before approving Merck’s chronic cough drug

Pharmaceutical company Merck has revealed that gefapixant, its experimental drug designed to address chronic cough, still has a ways to go before hitting the US market. As part of its announcement, Merck said it has received a Complete Response Letter (CRL) from the FDA seeking more details about the drug's efficacy, meaning the agency has declined to approve the treatment at this time.

Continue Reading

Elon Musk’s brain chip company Neuralink aims for clinical trials

Elon Musk’s brain chip company Neuralink aims for clinical trials

Thinking of Elon Musk usually produces an image of a Tesla or simply a mountain of money, but soon enough, this might change. Musk is the co-founder of Neuralink, a company that produces microchips meant to one day help paralyzed people navigate the world with their brain. The development of the microchips is well underway, and the company has just started recruiting staff to soon begin clinical trials on humans.

Continue Reading

Oxford warns mild COVID can reduce cognitive performance for months

Oxford warns mild COVID can reduce cognitive performance for months

Mild cases of COVID-19 that don't result in obvious "long COVID" symptoms may still trigger memory and attention problems, according to a new study from the University of Oxford. Though participants who'd previously had and recovered from mild COVID were found to have similar test results as the study's control group, there were two areas related to cognitive performance that were noticeably worse.

Continue Reading

Cancer-targeting treatment “steps on the gas” to kill tumors

Cancer-targeting treatment “steps on the gas” to kill tumors

Many have heard of immunosuppressive drugs, which are a type of medication that suppresses the immune system, but lesser-known are immunostimulatory drugs, which stimulate the body's immune system. The latter is a potential solution for treating cancerous tumors, as the drugs trigger the immune system to attack the mutated cells. The problem? Ordinarily, such drugs could also cause the immune system to become overstimulated, attacking healthy cells with serious -- sometimes deadly -- consequences.

Continue Reading

Terminally ill U.S. man gets a pig’s heart with a successful transplant

Terminally ill U.S. man gets a pig’s heart with a successful transplant

The organ donor crisis has long inspired the medical fraternity to look for feasible donors from other species. This week, doctors at the University of Maryland School of Medicine (UMSOM) have successfully executed the world's first heterologous heart transplant, placing a genetically-modified pig's heart into a terminally ill human being. Note: This article contains imagery and descriptions of human and animal surgery and xenotransplantation. Some readers may find this content upsetting.

Image: Coryn/Shutterstock

Continue Reading

The Pfizer COVID Omicron Booster Is Already In Production

The Pfizer COVID Omicron Booster Is Already In Production

Pfizer has announced its Omicron COVID-19 booster is already in production as the variant has led to a massive increase in cases worldwide, accounting for as many as 95% of new cases in the US (via OHS).

Continue Reading

The FDA just changed the Moderna COVID booster rules

The FDA just changed the Moderna COVID booster rules

The U.S. Food and Drug Administration (FDA) has announced a change to how long adults must wait before they can get the Moderna COVID-19 vaccine booster shot. Starting immediately, individuals aged 18 and older can now get their booster shot after at least five months have passed since the completion of the primary series of the Moderna vaccine.

Continue Reading

This rescue drone saved a dying man’s life

This rescue drone saved a dying man’s life

To many, drones still seem like mildly annoying toys, but the truth is that they have the potential to be a lot more. This was proven by Everdrone, a Swedish company that develops drone-related tech with a strong focus on making autonomous drones useful within the emergency response and healthcare fields. In December 2021, an Everdrone device became the first drone ever to be partially responsible for saving a dying man's life.

Continue Reading

FDA Expands COVID Boosters To Younger Children

FDA Expands COVID Boosters To Younger Children

The Food and Drug Administration (FDA) has taken multiple actions to expand vaccine availability for children in an effort to combat the COVID-19 virus, including authorizing a booster dose for children. Two years into the pandemic and the world is once again experiencing another major surge in cases, this time driven by the Omicron variant. Omicron has a record number of mutations, compared with previous variants, with more than 30 of those mutations in the spike protein that helps it spread (via Scientific American).

Continue Reading

COVID-19 antiviral pill gets FDA authorization: Here’s the small print

COVID-19 antiviral pill gets FDA authorization: Here’s the small print

Pfizer's Paxlovid is the first oral COVID-19 treatment to get FDA authorization for use in the US. The health agency announced its decision today, noting that it is only available for certain patients. Though Paxlovid won't protect you from developing COVID-19, taking it early enough may prevent the infection from becoming severe.

Continue Reading

CDC says COVID-19 variant Omicron is already dominant in the US

CDC says COVID-19 variant Omicron is already dominant in the US

The SARS-CoV-2 virus has mutated over the past couple of years, with some mutations fading away fairly quickly and others leading to the rise of new "variants of concern." The CDC monitors these variants through genomic sequencing and regularly updates data on which strains are circulating in the US. The health agency updated its tracker with the latest data this week, revealing the omicron variant is now responsible for more COVID-19 cases than delta.

Continue Reading

1 2 3 4 Next